Primary Hyperparathyroidism: Clinical Trials

6 trials for Primary Hyperparathyroidism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated, 1 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 2, Recruiting 2, Terminated 1, Unknown 1

Follow Primary Hyperparathyroidism: new trials by email Literature Review of Primary Hyperparathyroidism trials Research Report on Primary Hyperparathyroidism

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism
Zoledronic acid 4 mg, Natriumklorid 9 mg/ml, Fresenius Kabi - Primary Hyperparathyroidism
Phase 4RecruitingUniversity of Aarhus1402025-03-012026-10-01
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
Calcitonin - Primary Hyperparathyroidism, Hypercalcemia
Phase 4RecruitingJoseph Sferra372019-05-292024-09-19
Osteoporosis in Primary Hyperparathyroidism
Denosumab 60 MG/ML Prefilled Syringe [Prolia], Zoledronic Acid - Primary Hyperparathyroidism, Osteoporosis
Phase 4UnknownUniversity Medical Centre Ljubljana402019-05-082022-11-04
Denosumab in Primary Hyperparathyroidism
Denosumab, Placebo - Primary Hyperparathyroidism
Phase 4TerminatedColumbia University82012-01-012022-11-02
Vitamin D Repletion in Primary Hyperparathyroidism
10,000 IU Vitamin D3, Placebo, Vitamin D - Primary Hyperparathyroidism, Vitamin D Deficiency
Phase 4CompletedColumbia University92011-10-012019-04-16
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Strontium Ranelate + Ca/Vitamin-D, Placebo - Primary Hyperparathyroidism, Osteopenia
Phase 4CompletedMedical University of Vienna632010-09-012015-01-21

Narrower conditions

Hyperparathyroidism, Primary (6)  ·  Bone Diseases, Metabolic (3)  ·  Osteoporosis (2)  ·  Hypercalcemia (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Endocrine System Diseases (6)  ·  Hyperparathyroidism (6)  ·  Parathyroid Diseases (6)  ·  Metabolic Diseases (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Bone Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Avitaminosis (1)  ·  Bone Diseases, Metabolic (1)  ·  Calcium Metabolism Disorders (1)  ·  Deficiency Diseases (1)  ·  Malnutrition (1)  ·  Nutrition Disorders (1)  ·  Water-Electrolyte Imbalance (1)

Interventions

Denosumab (2)  ·  Zoledronic Acid (2)  ·  Calcitonin (1)  ·  Cholecalciferol (1)  ·  Saline Waters (1)  ·  Vitamin D (1)  ·  salmon calcitonin (1)  ·  strontium ranelate (1)

Sponsors

Columbia University (2)  ·  Joseph Sferra (1)  ·  Medical University of Vienna (1)  ·  University Medical Centre Ljubljana (1)  ·  University of Aarhus (1)

Countries

United States (3)  ·  Austria (1)  ·  Denmark (1)  ·  Slovenia (1)

Top investigators

Bruno Niederle, Prof., MD (1)  ·  John P Bilezikian, MD (1)  ·  Joseph Sferra, MD (1)  ·  Lars Rejnmark, Professor (1)  ·  Shonni J Silverberg, MD (1)  ·  Tomaz Kocjan, MD, PhD (1)

NIH funding

2008 (1), 2023 (1), R01DK032333 (1), R01DK084986 (1)